Hot Features
プレミアム
Atea Pharmaceuticals Inc (AVIR)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | Mr. Bruno LucidiIndependent Director | 29.60k | 0.00 | Derivative Exercise and Retained Stock | - | 142.35k | 26.25% |
| 2026-06-18 | Mr. Franklin M. BergerLead Independent Director | 29.60k | 0.00 | Derivative Exercise and Retained Stock | - | 536.10k | 5.84% |
| 2026-06-18 | Ms. Barbara G. DuncanIndependent Director | 29.60k | 0.00 | Derivative Exercise and Retained Stock | - | 92.35k | 47.17% |
| 2026-06-18 | Dr. Jerome M. AdamsIndependent Director | 29.60k | 0.00 | Derivative Exercise and Retained Stock | - | 92.35k | 47.17% |
| 2026-06-18 | Dr. Bruce W. PolskyIndependent Director | 29.60k | 0.00 | Derivative Exercise and Retained Stock | - | 124.81k | 31.09% |
| 2026-06-18 | Dr. Polly A. MurphyIndependent Director | 29.60k | 0.00 | Derivative Exercise and Retained Stock | - | 121.75k | 32.12% |
| 2026-05-18 | Dr. Polly A. MurphyIndependent Director | 6.10k | 25.45k | 買い | 4.17 | 92.15k | 7.09% |
| 2026-03-11 | Ms. Andrea J. CorcoranCFO, Exec. VP of Legal & Secretary | 60.00k | 74.40k | Derivative Exercise and Retained Stock | 1.24 | 823.58k | 7.86% |
| 2026-01-31 | Dr. Maria Arantxa HorgaChief Medical Officer | 35.21k | 0.00 | Derivative Exercise and Retained Stock | - | 96.09k | 57.84% |
| 2026-01-31 | Dr. Maria Arantxa HorgaChief Medical Officer | -16.07k | 68.15k | Derivative Exercise and Sale | 4.24 | 96.09k | - |
| 2026-01-31 | Mr. John F. VavrickaChief Commercial Officer | 30.51k | 0.00 | Derivative Exercise and Retained Stock | - | 165.10k | 22.67% |
| 2026-01-31 | Mr. John F. VavrickaChief Commercial Officer | -11.57k | 49.06k | Derivative Exercise and Sale | 4.24 | 165.10k | - |
| 2026-01-31 | Ms. Andrea J. CorcoranCFO, Exec. VP of Legal & Secretary | 38.76k | 0.00 | Derivative Exercise and Retained Stock | - | 763.58k | 5.35% |
| 2026-01-31 | Ms. Andrea J. CorcoranCFO, Exec. VP of Legal & Secretary | -16.10k | 68.28k | Derivative Exercise and Sale | 4.24 | 763.58k | - |
| 2026-01-31 | Dr. Janet M. J. HammondChief Development Officer | 43.91k | 0.00 | Derivative Exercise and Retained Stock | - | 127.67k | 52.43% |
| 2026-01-31 | Dr. Janet M. J. HammondChief Development Officer | -14.14k | 59.94k | Derivative Exercise and Sale | 4.24 | 127.67k | - |
| 2026-01-31 | Dr. Jean-Pierre SommadossiFounder, Chairman, CEO & President | 466.89k | 372.00k | Derivative Exercise and Retained Stock | 1.24 | 6.63M | 7.57% |
| 2026-01-31 | Dr. Jean-Pierre SommadossiFounder, Chairman, CEO & President | -106.09k | 449.83k | Derivative Exercise and Sale | 4.24 | 6.63M | - |
| 2026-01-31 | Mr. Wayne FosterExec. VP of Finance & CAO | 29.20k | 0.00 | Derivative Exercise and Retained Stock | - | 79.33k | 58.25% |
| 2026-01-31 | Mr. Wayne FosterExec. VP of Finance & CAO | -12.13k | 51.44k | Derivative Exercise and Sale | 4.24 | 79.33k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
